Soft drinks group Nichols said its first-quarter revenue had fallen, owing to weakness in the UK out-of-home route to market, but guides for profit in...
Intellectual property company Frontier IP said it expected results for the year ending 30 June 2021, would be 'materially' ahead of management expectations following increase...
Regenerative medical devices company Tissue Regenix posted a deeper annual loss as sales slipped and it wrote down the value of its CellRight Technologies business,...
RNA-based therapy developer Silence Therapeutics said it had achieved another research milestone as part of an ongoing collaboration with Mallinckrodt for complement-mediated diseases.
ICG Enterprise Trust reported that total returns that were up up 22.5% for the year, following an 11.8% climb during the final quarter following 'excellent'...